CSIMarket


Penumbra Inc   (PEN)
Other Ticker:  
 

Penumbra Inc

PEN's Fundamental analysis








Looking into Penumbra Inc growth rates, revenue grew by 28.69 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 931

Medical Equipment & Supplies industry recorded growth of revenues by 7.86 %

Penumbra Inc 's net income grew by 1298.45 % in IV. Quarter 2023 year on year, above company average,

More on PEN's Growth


Penumbra Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Penumbra Inc PEG ratio is at -0.03 Company is currently trading with Price to Cash flow multiple of 94.34 in trailing twelve-month period.
Company
103.81
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.7.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.36.


More on PEN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.13
 Tangible Book Value (Per Share $) 24.02

Penumbra Inc
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Penumbra Inc PEG ratio is at -0.03 Company is currently trading with Price to Cash flow multiple of 94.34 in trailing twelve-month period.
Company
103.81
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.7.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.36.

Penumbra Inc Price to Book Ratio is at 7.81 higher than Indusry Avg. of -347.43, and higher than S&P 500 Avg. of -2032.6

More on PEN's Valuation

  Market Capitalization (Millions $) 9,210
  Shares Outstanding (Millions) 39
  Employees -
  Revenues (TTM) (Millions $) 1,059
  Net Income (TTM) (Millions $) 91
  Cash Flow (TTM) (Millions $) 98
  Capital Exp. (TTM) (Millions $) -15
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 5.13
  Tangible Book Value (Per Share $) 24.02

  Market Capitalization (Millions $) 9,210
  Shares Outstanding (Millions) 39
  Employees -
  Revenues (TTM) (Millions $) 1,059
  Net Income (TTM) (Millions $) 91
  Cash Flow (TTM) (Millions $) 98
  Capital Exp. (TTM) (Millions $) -15


    PEN's Profitability Comparisons
Penumbra Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 12.3 % from 4.66 % in III. Quarter.

Penumbra Inc net profit margin of 19.05 % is currently ranking no. 9 in Medical Equipment & Supplies industry, ranking no. 42 in Healthcare sector and number 427 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 6.06
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.4
  Asset Turnover Ratio (TTM) 0.8
  Inventory Turnover Ratio (TTM) 1.03



Penumbra Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2023 to 12.3 % from 4.66 % in III. Quarter.

Penumbra Inc net profit margin of 19.05 % is currently ranking no. 9 in Medical Equipment & Supplies industry, ranking no. 42 in Healthcare sector and number 427 in S&P 500.

More on PEN's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com